Article

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma

2021-06-17

Abstract excerpt

<h4>Purpose: </h4> Melanoma’s incidence is increasing, and elderly people could be significantly impacted since the majority occurs in people over 65 years of age. Combined targeted therapies (TT) are current standard regimen for BRAF mutated metastatic melanoma (MM). Except for subgroups of pivotal trials, little data are available for TT in this population. <h4>Materials and Methods:</h4> Outcomes were exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ab0d80a-26c8-5bff-b52e-95d972bf09df
DOI: 10.20944/preprints202106.0460.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic MelanomaDOI 10.20944/preprints202106.0460.v1Read

Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.Semantic proximity Read

Management of advanced melanoma in the current era: A medical oncology perspective for the Indian scenario.Semantic proximity Read

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.Semantic proximity Read

Improving patient outcomes to targeted therapies in melanoma.Semantic proximity Read

Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st-line BRAF-targeted therapy.Semantic proximity Read

Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL).Semantic proximity Read

[Clinical studies and accepted therapies of advanced melanoma].Semantic proximity Read

Metastatic melanoma treatment: Combining old and new therapies.Semantic proximity Read

First line treatment of BRAF mutated advanced melanoma: Does one size fit all?Semantic proximity Read

Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Semantic proximity Read

Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience.Semantic proximity Read

French updated recommendations in Stage I to III melanoma treatment and management.Semantic proximity Read